• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

最小化伤害和管理疼痛:老年人群中减少阿片类药物的使用。

Minimising Harm and Managing Pain: Deprescribing Opioids in Older Adults.

机构信息

Faculty of Medicine and Health, School of Pharmacy, The University of Sydney, Rm 401, Badham Building A16, Camperdown, 2006, Sydney, NSW, Australia.

Faculty of Pharmacy and Pharmaceutical Sciences, Centre for Medicine Use and Safety, Monash University, Parkville, VIC, Australia.

出版信息

Drugs Aging. 2024 Nov;41(11):863-871. doi: 10.1007/s40266-024-01154-5. Epub 2024 Oct 29.

DOI:10.1007/s40266-024-01154-5
PMID:39467997
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11554919/
Abstract

Approximately one in three older adults (aged 65 years and over) experience pain, negatively impacting their quality of life. Opioid analgesics are commonly prescribed to manage pain; however, balancing the benefits and harms of these high-risk analgesics can be challenging for both healthcare professionals and patients. This is particularly true for older adults, as factors such as polypharmacy, age-related physiological changes and cognitive decline may impact upon opioid safety and efficacy. Deprescribing is the patient-centred process of reducing or discontinuing a medication that is no longer appropriate, or where the risks of continuation are deemed to outweigh the anticipated benefits. Opioid deprescribing has been proposed as a mechanism to reduce individual and societal opioid-related harm; however, to date, research has predominantly focused on the general adult population, rather than older adults. This current opinion aims to summarise the existing opioid deprescribing literature, discussing its applicability for older adults. Drawing on a non-systematic review of the literature, it identifies unique challenges and considerations for this population, highlights international initiatives to enhance opioid deprescribing in clinical practice and proposes future directions to advance the field.

摘要

大约三分之一的老年人(65 岁及以上)经历疼痛,这对他们的生活质量产生负面影响。阿片类镇痛药常用于治疗疼痛;然而,对于医疗保健专业人员和患者来说,平衡这些高风险镇痛药的益处和危害可能具有挑战性。对于老年人来说尤其如此,因为多药治疗、与年龄相关的生理变化和认知能力下降等因素可能会影响阿片类药物的安全性和疗效。药物减量是指患者为减少或停止使用不再合适的药物,或者继续使用药物的风险被认为超过预期收益而采取的以患者为中心的过程。阿片类药物减量被提议作为一种减少个体和社会阿片类药物相关伤害的机制;然而,迄今为止,研究主要集中在普通成年人群体,而不是老年人。本当前观点旨在总结现有的阿片类药物减量文献,讨论其对老年人的适用性。通过对文献的非系统性回顾,它确定了该人群的独特挑战和考虑因素,强调了提高临床实践中阿片类药物减量的国际举措,并提出了推进该领域的未来方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41db/11554919/d8d425d9724f/40266_2024_1154_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41db/11554919/d8d425d9724f/40266_2024_1154_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41db/11554919/d8d425d9724f/40266_2024_1154_Fig1_HTML.jpg

相似文献

1
Minimising Harm and Managing Pain: Deprescribing Opioids in Older Adults.最小化伤害和管理疼痛:老年人群中减少阿片类药物的使用。
Drugs Aging. 2024 Nov;41(11):863-871. doi: 10.1007/s40266-024-01154-5. Epub 2024 Oct 29.
2
Clinical practice guideline for deprescribing opioid analgesics: summary of recommendations.临床实践指南:减少阿片类镇痛药剂量的建议摘要。
Med J Aust. 2023 Jul 17;219(2):80-89. doi: 10.5694/mja2.52002. Epub 2023 Jun 25.
3
Older Adult and Primary Care Practitioner Perspectives on Using, Prescribing, and Deprescribing Opioids for Chronic Pain.老年人和初级保健医生对使用、开处和停用阿片类药物治疗慢性疼痛的看法。
JAMA Netw Open. 2024 Mar 4;7(3):e241342. doi: 10.1001/jamanetworkopen.2024.1342.
4
Optimizing Pain Management Through Opioid Deprescribing.通过减少阿片类药物使用来优化疼痛管理。
J Gerontol Nurs. 2018 Jan 1;44(1):9-14. doi: 10.3928/00989134-20171213-04.
5
Exploring the facilitators and barriers in opioid deprescribing for non-cancer pain treatment experienced by general practitioners: A qualitative study.探讨全科医生在非癌性疼痛治疗中减少阿片类药物使用的促进因素和障碍:一项定性研究。
Eur J Pain. 2024 Aug;28(7):1101-1115. doi: 10.1002/ejp.2243. Epub 2024 Jan 30.
6
Opioid deprescribing: Qualitative perspectives from those with chronic non-cancer pain.阿片类药物减用:慢性非癌痛患者的定性观点。
Res Social Adm Pharm. 2022 Dec;18(12):4083-4091. doi: 10.1016/j.sapharm.2022.07.043. Epub 2022 Aug 5.
7
Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis.针对多病共存和多种药物治疗的老年人减药:TAILOR 证据综合。
Health Technol Assess. 2022 Jul;26(32):1-148. doi: 10.3310/AAFO2475.
8
Patient Perceptions of Opioids and Benzodiazepines and Attitudes Toward Deprescribing.患者对阿片类药物和苯二氮䓬类药物的认知以及对减药的态度。
Drugs Aging. 2023 Dec;40(12):1113-1122. doi: 10.1007/s40266-023-01071-z. Epub 2023 Oct 4.
9
Determinants of successful opioid deprescribing: Insights from French pain physicians-A qualitative study.阿片类药物成功减药的决定因素:来自法国疼痛科医生的见解——一项定性研究。
Pain Pract. 2025 Jan;25(1):e13409. doi: 10.1111/papr.13409. Epub 2024 Aug 28.
10
Deprescribing Opioids in Chronic Non-cancer Pain: Systematic Review of Randomised Trials.在慢性非癌痛中减少阿片类药物的使用:随机试验的系统评价。
Drugs. 2020 Oct;80(15):1563-1576. doi: 10.1007/s40265-020-01368-y.

引用本文的文献

1
Drugs and Healthy Aging.药物与健康老龄化
Drugs Aging. 2025 Jul;42(7):591-598. doi: 10.1007/s40266-025-01208-2. Epub 2025 Jul 3.

本文引用的文献

1
Rural-urban residence and life expectancies with and without pain.农村-城市居住与有无疼痛的预期寿命。
Health Place. 2024 Sep;89:103305. doi: 10.1016/j.healthplace.2024.103305. Epub 2024 Jul 4.
2
Government Direct-to-Consumer Education to Reduce Prescription Opioid Use: A Cluster Randomized Clinical Trial.政府面向消费者的直接教育以减少处方阿片类药物使用:一项集群随机临床试验。
JAMA Netw Open. 2024 May 1;7(5):e2413698. doi: 10.1001/jamanetworkopen.2024.13698.
3
What do clinical practice guidelines say about deprescribing? A scoping review.
临床实践指南对减药有何看法?一项范围综述。
BMJ Qual Saf. 2024 Dec 13;34(1):28-39. doi: 10.1136/bmjqs-2024-017101.
4
Perspectives on approaching pain management in patients with dementia.对痴呆症患者疼痛管理方法的看法。
Pain Manag. 2024 Mar;14(3):153-161. doi: 10.2217/pmt-2023-0095. Epub 2024 Mar 25.
5
Age, Race, Ethnicity, and Sex of Participants in Clinical Trials Focused on Chronic Pain.临床试验中慢性疼痛参与者的年龄、种族、民族和性别。
J Pain. 2024 Aug;25(8):104511. doi: 10.1016/j.jpain.2024.03.007. Epub 2024 Mar 16.
6
Older Adult and Primary Care Practitioner Perspectives on Using, Prescribing, and Deprescribing Opioids for Chronic Pain.老年人和初级保健医生对使用、开处和停用阿片类药物治疗慢性疼痛的看法。
JAMA Netw Open. 2024 Mar 4;7(3):e241342. doi: 10.1001/jamanetworkopen.2024.1342.
7
Age-Related Risk of Serious Fall Events and Opioid Analgesic Use.与年龄相关的严重跌倒事件和阿片类镇痛药使用风险。
JAMA Intern Med. 2024 Apr 1;184(4):394-401. doi: 10.1001/jamainternmed.2023.8154.
8
Impact of demographic factors on chronic pain among adults in the United States.人口因素对美国成年人慢性疼痛的影响。
Pain Rep. 2022 Jun 6;7(4):e1009. doi: 10.1097/PR9.0000000000001009. eCollection 2022 Jul-Aug.
9
'It was a joint plan we worked out together'. How the I-WOTCH programme enabled people with chronic non-malignant pain to taper their opioids: a process evaluation.“这是我们一起制定的联合计划”。I-WOTCH 项目如何使慢性非恶性疼痛患者逐渐减少阿片类药物用量:过程评估。
BMJ Open. 2023 Dec 6;13(12):e074603. doi: 10.1136/bmjopen-2023-074603.
10
Context matters: using an Evidence to Decision (EtD) framework to develop and encourage uptake of opioid deprescribing guideline recommendations at the point-of-care.背景很重要:运用证据到决策(EtD)框架,在医疗现场制定并鼓励采用阿片类药物减药指南建议。
J Clin Epidemiol. 2024 Jan;165:111204. doi: 10.1016/j.jclinepi.2023.10.020. Epub 2023 Nov 4.